Carson Wealth (CWM LLC)
ABEO icon

Carson Wealth (CWM LLC)’s Abeona Therapeutics ABEO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336 Buy
75
+20
+36% +$100 ﹤0.01% 5490
2025
Q4 		$0 Sell
55
-39
-41% -$196 ﹤0.01% 5341
2025
Q3 		$0 Buy
+94
New +$596 ﹤0.01% 5231

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ABEO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Abeona Therapeutics (ABEO) stake by 36% in Q1 2026, buying an estimated $100 and bringing the position to 75 shares worth $336. The position accounts for ﹤0.01% of the portfolio, ranked #5490.

Carson Wealth (CWM LLC) first reported a position in ABEO in Q3 2025 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 75 shares of Abeona Therapeutics worth $336 as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 20 Abeona Therapeutics shares in Q1 2026, an estimated $100.
  • Abeona Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5490 holding.
  • Carson Wealth (CWM LLC) first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.